Skip to content

Categories: umandiagnostics

  • Niklas Norgren, VP and Managing director at UmanDiagnostics, with newly recruited Maria Hörnberg and Ronja Lindgren. With the autumn's new hires, the in vitro diagnostics company has gone from being a micro to a small business.

    UmanDiagnostics continues to expand with recruitment of two new members of staff

    The in vitro diagnostics company UmanDiagnostics has gone from being a micro business to a small business. The company specializes in nerve injury markers and the Neurofilament light protein (NFL), which makes it easier to find and diagnose neurological diseases such as Multiple Sclerosis, ALS, and Alzheimer's disease.

  • UmanDiagnostics is expanding its current premises in Umeå with 180 square meters, to a total of 630 square meters. From the left: Niklas Norgren, VP and Managing director, with Eva Söderström, Carola Falk and Andreas Gunnarsson at UmanDiagnostics.

    UmanDiagnostics expands to meet demand

    "This expansion will enable us to increase productivity and deliver more products to the market”, says Niklas Norgren, VP and Managing Director.

  • Niklas Norgren.

    UmanDiagnostics launches new product that can revolutionize research in neurological diseases

    Swedish-based UmanDiagnostics, a Quanterix company, has developed a new type of product that makes it easier to detect neurological diseases. Called NF-light ™ serum ELISA, it was officially launched on October 12th and will now be sold worldwide.

    “Our product can be used for research inthe field of neurological diseases throughout the world. It feels very exciting, because our product is c